دورية أكاديمية

Pregabalin for the treatment of generalized anxiety disorder

التفاصيل البيبلوغرافية
العنوان: Pregabalin for the treatment of generalized anxiety disorder
المؤلفون: A. Khallouk, A. Rhaouti, A. Boukdir, S. Stati, H. Nafiaa, A. Ouanass
المصدر: European Psychiatry, Vol 65, Pp S399-S399 (2022)
بيانات النشر: Cambridge University Press, 2022.
سنة النشر: 2022
المجموعة: LCC:Psychiatry
مصطلحات موضوعية: disorder, Treatment, Anxiety, pregabalin, Psychiatry, RC435-571
الوصف: Introduction Pregabalin is a treatement with a complexe mechanism of action. It’s an antiepileptic drug used as adjunctive treatment of partial epilepsy, it is also taken in the treatment of neuropathic pain, and generalized anxiety disorder, in addition to epilepsy. Some of the advantages of pregabalin include. pharmacokinetics, safety, and tolerability. Clinical trials have demonstrated the efficacy of pregabalin comparable to benzodiazepines, without risk of abuse. Objectives to assess the efficacy of pregabalin in patients with generalized anxiety disorder in the Ar-Razi university psychiatric hospital in Salé in Morocco Methods To assess the place of pregabalin in the treatement of anxiety disorders through patients hospitalized in the Ar-Razi university psychiatric hospital in Salé in Morocco The evaluation instruments are: For anxiety the Hamilton Anxiety Scale and For therapeutic efficacy CGI-therapeutic index Results based on the results of our study on the patients who have improved after an optimal duration of treatment, in conjunction with psychological monitoring, we retain that pregabalin can significantly improve the quality of life of anxious patients and also guarantee them a better prognosis Conclusions Pregabalin was significantly more efficacious for the treatment of psychic and somatic symptoms of generalized anxiety disorder and was well tolerated by most study patients. Disclosure No significant relationships.
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 0924-9338
1778-3585
Relation: https://www.cambridge.org/core/product/identifier/S0924933822010112/type/journal_article; https://doaj.org/toc/0924-9338; https://doaj.org/toc/1778-3585
DOI: 10.1192/j.eurpsy.2022.1011
URL الوصول: https://doaj.org/article/ce21742a6c2541d2a758bc6f4faab381
رقم الأكسشن: edsdoj.21742a6c2541d2a758bc6f4faab381
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:09249338
17783585
DOI:10.1192/j.eurpsy.2022.1011